ArticleJournal of bone oncology2022

Risk factors associated with skeletal-related events following discontinuation of denosumab treatment among patients with bone metastases from solid tumors: A real-world machine learning approach.

Dionna Jacobson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.